Real-world pharmacovigilance analysis of galsulfase: a study based on the FDA adverse event reporting system (FAERS) database.

Naglazyme (galsulfase) - AnGes MG, BioMarin

http://www.ncbi.nlm.nih.gov/pubmed/39161895

Jiao Qian; Jun Yang; Junjie Zou; Runcheng Huang; Shangze Li; Yijia Liu; Yuanyuan Meng

Aug 20, 2024